195 related articles for article (PubMed ID: 24770363)
1. [Voluntary mediation in healthcare disputes: the experience of the "Fondazione IRCCS Istituto Nazionale dei Tumori" in Milan (Italy)].
Tereanu C; Bettega S; Regalia E; Mazza R; Greco M; Lozza L; Saita L; Borreani C; Quattrocolo A
Ig Sanita Pubbl; 2014; 70(1):29-40. PubMed ID: 24770363
[TBL] [Abstract][Full Text] [Related]
2. [Report on the activity of the Istituto nazionale per lo studio e la cura dei tumori of Milan 1949].
RONDONI P
Tumori; 1950; 36(1):35-46. PubMed ID: 15418639
[No Abstract] [Full Text] [Related]
3. [Adolescents with cancer: the "Youth Project" at the Istituto Nazionale Tumori in Milan].
Ferrari A; Veneroni L; Clerici CA; Spreafico F; Terenziani M; Massimino M; Luksch R; Casanova M; Meazza C; Polastri D; Gandola L
Recenti Prog Med; 2013 Jan; 104(1):10-6. PubMed ID: 23439535
[TBL] [Abstract][Full Text] [Related]
4. The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes.
Magnani T; Valdagni R; Salvioni R; Villa S; Bellardita L; Donegani S; Nicolai N; Procopio G; Bedini N; Rancati T; Zaffaroni N
BJU Int; 2012 Oct; 110(7):998-1003. PubMed ID: 22404874
[TBL] [Abstract][Full Text] [Related]
5. The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation process.
De Feo G; D'Ambrosio F; Palmieri G; Perrone F; Ciliberto G
Tumori; 2015; 101 Suppl 1():S33-7. PubMed ID: 27096270
[TBL] [Abstract][Full Text] [Related]
6. [The out-patient clinic for medical oncology treatment. Experience at the Istituto Nazionale Tumori of Milan (author's transl)].
De Lena M; Tancini G; Brambilla C; Rossi A; Musumeci R; Marchesi M; Cipriani S; Monfardini S; Petrillo R; Franchi F; Del Vecchio M
Tumori; 1976; 62(6):576-86. PubMed ID: 1030863
[TBL] [Abstract][Full Text] [Related]
7. Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di Milano.
Valenza F; Papagni G; Marchianò A; Daidone MG; DeBraud F; Colombo MP; Frignani A; Galmozzi G; Ladisa V; Pruneri G; Salvioni R; Spada P; Torresani M; Rinaldi O; Manfredi S; Votta M; Apolone G
Tumori; 2020 May; ():300891620923790. PubMed ID: 32364028
[TBL] [Abstract][Full Text] [Related]
8. The TELECOS project: the experience of the Istituto Nazionale dei Tumori of Milano.
Galante E
Rays; 1991; 16(4):456-62. PubMed ID: 1788412
[No Abstract] [Full Text] [Related]
9. The practice of mediation to resolve clinical, bioethical, and medical malpractice disputes.
Lee DW; Lai PB
Hong Kong Med J; 2015 Dec; 21(6):560-4. PubMed ID: 26634373
[TBL] [Abstract][Full Text] [Related]
10. Let's talk conflict: using mediation in healthcare security disputes.
Armstrong B
J Healthc Prot Manage; 2013; 29(1):96-108. PubMed ID: 23513710
[TBL] [Abstract][Full Text] [Related]
11. Viral!: The propagation of a Christmas Carol produced by adolescent cancer patients at the Istituto Nazionale Tumori in Milan, Italy.
Ferrari A; Signoroni S; Silva M; Gaggiotti P; Veneroni L; Clerici CA; Massimino M
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28266763
[No Abstract] [Full Text] [Related]
12. An integrated approach to safety-driven and ICT-enabled process reengineering: methodological advice and a case study.
Langer M; Castellari R; Locatelli P; Sini E; Torresani M; Facchini R; Moser R
Stud Health Technol Inform; 2014; 201():203-10. PubMed ID: 24943545
[TBL] [Abstract][Full Text] [Related]
13. [Chordoma: study of 245 cases verified at the Istituto Nazionale dei Tumori de Milano (Italy)].
Brondi LA; Podrecca S; Cataldo I
Rev Paul Med; 1980; 95(3-4):71-3. PubMed ID: 7209261
[No Abstract] [Full Text] [Related]
14. Anticancer innovative therapy: Highlights from the ninth annual meeting.
Volpari T; De Santis F; Bracken AP; Pupa SM; Buschbeck M; Wegner A; Di Cosimo S; Lisanti MP; Dotti G; Massaia M; Pruneri G; Anichini A; Fortunato O; De Braud F; Del Vecchio M; Di Nicola M
Cytokine Growth Factor Rev; 2020 Feb; 51():1-9. PubMed ID: 31862236
[TBL] [Abstract][Full Text] [Related]
15. Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.
Costa C; Indovina P; Mattioli E; Forte IM; Iannuzzi CA; Luzzi L; Bellan C; De Summa S; Bucci E; Di Marzo D; De Feo M; Mutti L; Pentimalli F; Giordano A
Cell Death Dis; 2020 Oct; 11(10):867. PubMed ID: 33067416
[TBL] [Abstract][Full Text] [Related]
16. Comment on "Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di Milano".
Romanzi A; Vannelli A
Tumori; 2020 Dec; 106(6):524-525. PubMed ID: 32867623
[TBL] [Abstract][Full Text] [Related]
17. Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting.
De Santis F; Del Vecchio M; Castagnoli L; De Braud F; Di Cosimo S; Franceschini D; Fucà G; Hiscott J; Malmberg KJ; McGranahan N; Pietrantonio F; Rivoltini L; Sangaletti S; Tagliabue E; Tripodo C; Vernieri C; Zitvogel L; Pupa SM; Di Nicola M
Cytokine Growth Factor Rev; 2018 Dec; 44():1-10. PubMed ID: 30393044
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary Versus One-on-One Setting: A Qualitative Study of Clinicians' Perceptions of Their Relationship With Patients With Prostate Cancer.
Bellardita L; Donegani S; Spatuzzi AL; Valdagni R
J Oncol Pract; 2011 Jan; 7(1):e1-5. PubMed ID: 21532797
[TBL] [Abstract][Full Text] [Related]
19. Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Madonna G; Masucci GV; Capone M; Mallardo D; Grimaldi AM; Simeone E; Vanella V; Festino L; Palla M; Scarpato L; Tuffanelli M; D'angelo G; Villabona L; Krakowski I; Eriksson H; Simao F; Lewensohn R; Ascierto PA
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439318
[TBL] [Abstract][Full Text] [Related]
20. [Turn-over of non-tenured public health research personnel in an Italian public research institute (IRCCS).].
Meneghini E; Lillini R; Ballarini R; Florita A; Cavallo I; Funaro F; Bonfarnuzzo S; Cifalà A; Margutti C; Perrotta I; Bonacci P; Carletti F; Fracchiolla V; Morelli M; Aiello A; Pizzo F; Gabaldi P; Apolone G; Baili P
Recenti Prog Med; 2019 Feb; 110(2):75-85. PubMed ID: 30843532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
